跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Pegylated interferon-alpha
首页
药物
Pegylated interferon-alpha
Pegylated interferon-alpha
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
PEGYLATED PORCINE INTERFERON AND METHODS OF USE THEREOF
EP 3471755 B1
申请人: ELANCO US INC
优先权: 2016
CN
EP
US
WO
8 件公开
Dimeric alpha interferon PEGylated site-specifically shows enhanced and prolonged efficacy in vivo
US 8158129 B2
申请人: CHANG CHIEN-HSING
优先权: 2011
US
5 件公开
US 8003111 B2
申请人: IBC PHARMACEUTICALS INC
优先权: 2010
US
2 件公开
Treatment of hepatitis C virus with telaprevir (VX-950) in patients non-responsive to treatment with pegylated interferon-alpha 2A/2B and ribavirin
US 8664273 B2
申请人: MCNAIR LINDSAY
优先权: 2009
CN
US
4 件公开
Melanoma therapy
US 6923966 B2
申请人: SCHERING CORP
优先权: 2001
US
4 件公开
Renal cell carcinoma treatment
US 2001053548 A1
申请人: RYBAK MARY ELLEN
优先权: 2001
US
2 件公开
Compositions comprising IMPDH inhibitors and uses thereof for treating HCV infection
US 7371372 B2
申请人: VERTEX PHARMA
优先权: 2004
US
2 件公开
Chicken albumin-interferon alpha-nterleukin 2 fusion protein, preparation method and coding gene thereof, and chicken pegylated interferon
CN 108864300 A
申请人: ANHUI JIUCHUAN BIOTECHNOLOGY CO LTD
优先权: 2017
CN
2 件公开
CML Therapy
US 6362162 B1
申请人: SCHERING CORP
优先权: 2000
US
Combination therapy for cancer
US 2002009428 A1
申请人: ZAKNOEN SARA L
优先权: 2001
US
US 2004223951 A1
申请人: SCHERING CORP
优先权: 2004
US
Method for treating hepatitis C
US 2001046957 A1
申请人: GRAVES MARY
优先权: 2001
US
第 1 / 3 页
上一页
下一页
药物
反馈